USA – Wesper, a NYC-based provider of a clinical-grade FDA cleared platform to bring the full cycle of sleep therapy to home users, raised $7.5M in Series A funding.
The round was led by Ceros Capital Markets.The company intends to use the funds to accelerate growth and expand operations.Wesper offers access to sleep data so that professionals can provide care and grow sleep testing services. Its sensors and algorithms provide at-home medical diagnosis and ongoing measurement, before, during, and after treatment. With Wesper, users have access to customized, professional guidance from sleep specialists without having to leave their homes. 09/11/2022
